Phenglutarimide hydrochloride

LY367385 hydrochloride is a highly selective and potent mGluR1a antagonist. LY367385 hydrochloride has an IC 50 of 8.8 μM for inhibiting of quisqualate-induced phosphoinositide (PI) hydrolysis, compared with &gt:100 μM for mGlu5a. LY367385

General description This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate.

General description This substance is a primary reference substance with assigned absolute purity (considering chromatographic purity, water, residual solvents, inorganic impurities). The exact value can be found on the certificate.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

Application Methyl benzimidate hydrochloride was used: in the synthesis of chiral phenyldihydroimidazole derivative as imidating reagent to modify Lys residues of cyclic Lys-Gly-Asp peptide to afford acetimidate analogs in the synthesis of N

Product Application:Methyl benzimidate hydrochloride was used:in the synthesis of chiral phenyldihydroimidazole derivativeas imidating reagent to modify Lys residues of cyclic Lys-Gly-Asp peptide to afford acetimidate analogsin the synthesis of

Product Application:Methyl benzimidate hydrochloride was used:in the synthesis of chiral phenyldihydroimidazole derivativeas imidating reagent to modify Lys residues of cyclic Lys-Gly-Asp peptide to afford acetimidate analogsin the synthesis of

Product Application:Methyl benzimidate hydrochloride was used:in the synthesis of chiral phenyldihydroimidazole derivativeas imidating reagent to modify Lys residues of cyclic Lys-Gly-Asp peptide to afford acetimidate analogsin the synthesis of

Product Application:Methyl benzimidate hydrochloride was used:in the synthesis of chiral phenyldihydroimidazole derivativeas imidating reagent to modify Lys residues of cyclic Lys-Gly-Asp peptide to afford acetimidate analogsin the synthesis of

A blood-brain barrier permeable and bioavailable chromenone compound that acts as a potent, selective, and reversible antagonist of mGlu7 receptor (IC 50 = 3.5 and 2.

The Microlute&trade PLR method of phospholipid removal is specifically designed to enhance the flow of samples through the filter to maximize the recovery of analytes with unrivalled reproducibility.&nbsp Efficiently remove a wide range of

Biochem/physiol Actions ML309 is a potent and selective inhibitor of mutant isocitrate dehydrogenase 1 (IDH1) (R132H and R132C) that binds reversibly the enzyme. ML309 inhibits production of neomorphic 2-hydroxyglutarate in glioblastoma cell line.